Skip to main content
In Good Company with Nicolai Tangen

HIGHLIGHTS: Mala Gaonkar - Founder of SurgoCap Partners

10 min episode · 2 min read
·

Episode

10 min

Read time

2 min

Topics

Productivity, Health & Wellness, Relationships

AI-Generated Summary

Key Takeaways

  • Duration-focused moats: SurgoCap identifies great businesses by analyzing their technology stack maps, particularly in non-tech sectors like aerospace and medtech. The firm concentrates investments in four verticals where technology disruption creates durable competitive advantages, allowing companies to deploy capital at high incremental returns over three to five year cycles.
  • AI in medical imaging: Medical imaging accuracy and speed improved by seventy percent through AI applications in MRIs and CT scans. This advancement enables earlier detection of chronic diseases in aging populations, making preventive care more cost-effective. The shift from reactive to proactive healthcare delivery reduces overall system costs while improving patient outcomes.
  • Robotic surgery penetration: Three hundred million surgeries occur globally each year, with robotic surgery just beginning market penetration. Companies like Intuitive Surgical combine haptic feedback, mapping software, and advanced surgical technologies to reduce errors, simplify medical student training, and improve therapeutic outcomes while containing healthcare costs through better execution.
  • Private market disruption: Change happens at the edges, not the core, making private companies the most disruptive investment opportunities. Smaller private firms and emerging founders drive innovation at the margin across the four industry categories. Maintaining global networks to identify these edge opportunities provides insight into future market shifts before they reach public markets.

What It Covers

Mala Gaonkar, founder of SurgoCap Partners, explains her concentrated investment strategy focused on four verticals: enterprise data, financial services, healthcare, and industrial technologies. She grew the fund from $1.8 billion to $6 billion by identifying businesses with long-duration competitive moats.

Key Questions Answered

  • Duration-focused moats: SurgoCap identifies great businesses by analyzing their technology stack maps, particularly in non-tech sectors like aerospace and medtech. The firm concentrates investments in four verticals where technology disruption creates durable competitive advantages, allowing companies to deploy capital at high incremental returns over three to five year cycles.
  • AI in medical imaging: Medical imaging accuracy and speed improved by seventy percent through AI applications in MRIs and CT scans. This advancement enables earlier detection of chronic diseases in aging populations, making preventive care more cost-effective. The shift from reactive to proactive healthcare delivery reduces overall system costs while improving patient outcomes.
  • Robotic surgery penetration: Three hundred million surgeries occur globally each year, with robotic surgery just beginning market penetration. Companies like Intuitive Surgical combine haptic feedback, mapping software, and advanced surgical technologies to reduce errors, simplify medical student training, and improve therapeutic outcomes while containing healthcare costs through better execution.
  • Private market disruption: Change happens at the edges, not the core, making private companies the most disruptive investment opportunities. Smaller private firms and emerging founders drive innovation at the margin across the four industry categories. Maintaining global networks to identify these edge opportunities provides insight into future market shifts before they reach public markets.

Notable Moment

Gaonkar describes the investment business as purely meritocratic, stating she could be a green Martian with two horns but would still attract investors if she produced returns, emphasizing that performance matters more than any demographic characteristic in asset management.

Know someone who'd find this useful?

Episode Transcript

Hi, everybody. Tune in to this short version of the podcast, which we do every Friday. For the long version, tune in on Wednesdays. Hi, everybody. I'm Nicola Tangen, the CEO of the Norwegian Sovereign Wealth Fund. And today, I'm really happy because I'm here with Mala Gowncar, who I've known for a long time actually. Mala founded Surgocap with $1,800,000,000 and now it's at $6,000,000,000 And before that, she spent twenty three years as a founding partner of Lone Pine Capital, one of the most successful hedge funds of all times. Great to have you here. Great to be here, Nikolai. Thank you. Tell me about Sergio Cap Partners, you know, your company. Yeah. Servo Cap tries to do what many investment firms try to do. It tries to beat the market, over a three to five year cycle with less risk than the market. A risk defined as loss of capital, not volatility. And the way we try to achieve that is by identifying this very small handful of truly great businesses that exist in the world, and we do that through a our product is really our process, a very transparent process of looking for very specific factors that really are distillation, as you pointed out earlier, of my lessons I've learned, the many mistakes and lessons I've learned, from investing over twenty three years with some of the best, people in the business, my former colleagues at at Lone Pine. And so that distillation has led to SSURGO. There are many different factors that lead to identification of a truly brilliant business. But the way I define a great business is a business with very long duration motes, and duration really is our true differentiation. So motes being that it's difficult to compete with them, it's difficult to compete them up. How many great companies are there in the world? As I said, a small handful. I don't think there are that many. We focus on really four verticals where I think there is a bit of an edge, from a one very specific factor, is techno every business is a technology business. Mhmm. Right? So if you're an aerospace company or a medtech business or a financial data business, you are a technology company in your backbone. If you want to deliver at scale and with quality, you have to be a tech business. Mhmm. And I think understanding the tech stack map of businesses is something we spend a lot of time on, especially in non tech businesses. Mhmm. I think that's one. The second is how old technologies can disrupt in very new ways. So if you think about something like, we've talked about this, but the auto industry, which employs far more people in the tech industry, but is being disrupted right now by, you know, technology that was invented in 1976, you know, the, the the lithium ion battery. So I think that is, that's always interesting to me. Or, you …

Get the full transcript (1,924 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all In Good Company with Nicolai Tangen transcripts →

You just read a 3-minute summary of a 7-minute episode.

Get In Good Company with Nicolai Tangen summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

More from In Good Company with Nicolai Tangen

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Business Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into In Good Company with Nicolai Tangen.

Every Monday, we deliver AI summaries of the latest episodes from In Good Company with Nicolai Tangen and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime